Fermenta Biotech Ltd - 506414 - Interim Dividend And Record Date
Pursuant to Regulation 42 of the Listing Regulations, the Board has approved the payment of interim Dividend of Rs. 5 (Five) per equity share of Rs. 5 each (100%) for the financial year 2019-20 which will be paid to those shareholders / beneficial owners whose names appear in the Register of Members as on Monday, November 25, 2019 ('Record Date') Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Release Dated November 13, 2019
Further to our intimation regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, we hereby enclose a copy of Earnings Release of the Company for the quarter ended September 30, 2019. The said Earnings Release is also available on Company's website www.dil.net Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Financial Results - Regulation 30, 33 And 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
The Board has approved the unaudited financial results for the quarter and half year ended September 30, 2019 (Standalone and Consolidated), as enclosed. We are enclosing herewith Limited Review Report dated November 13, 2019 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Financial Results - Regulation 30, 33 And 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 30 and 33 of Listing Regulations, we write to inform you that the Board of Directors of the Company at its meeting held on November 13, 2019 has, inter alia, approved the following: (a) Unaudited financial results, The Board has approved the unaudited financial results for the quarter and half year ended September 30, 2019 (Standalone and Consolidated), as enclosed. (b) Wholly owned subsidiary in Germany, (c) Backward Integration, (d) Interim Dividend and Record Date, (e) Dividend Payment Date: Fermenta Biotech Ltd - 506414 - Publication In Newspapers - Notice Of 'Listing And Trading Of New Securities'
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Notice of 'Listing and Trading of New Securities' as per clause III (A) (5) of the SEBI Circular CFD/DIL3/CIR/2017/21 March 10, 2017 was published in the following issues on November 8, 2019 - 1. 'Financial Express' - All Editions, in English language; 2. 'Jansatta' - All Editions, in Hindi language and 3. 'Loksatta' - All Editions, in Marathi language. A copy of the notice published in newspapers is annexed to this letter and in also being uploaded on website of the Company at www.dil.net Please take this information on records. Fermenta Biotech Ltd - 506414 - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On November 13, 2019
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated November 4, 2019 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on November 13, 2019, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 3 and Sakal, Mumbai (Marathi version) on page no. 9 dated November 6, 2019 for your reference and record. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Investor Relations Presentation - Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation dated November 6, 2019 for your information. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Investor Relations Presentation - Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation dated November 6, 2019 for your information. DIL LTD. - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window
DIL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2019. Pursuant to our earlier Notice for the Closure of Trading Window dated October 1, 2019 and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has already been closed with effect from October 1, 2019 and shall continue to remain closed till 48 hours after declaration of financial results. DIL LTD. - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018 for the quarter ended September 30, 2019 ('Period') Please find enclosed herewith the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019 received from our Registrar and Transfer Agents - Link Intime India Private Limited.